Missingness rates | Â | Treatment | Time | Treatment x Time | Coverage probability | |||||
---|---|---|---|---|---|---|---|---|---|---|
5% | Analysis | Bias | RMSE | Bias | RMSE | Bias | RMSE | Treatment | Time | Treatment x Time |
 | ML | -0.063 | 0.127 | -0.005 | 0.015 | 0.028 | 0.033 | 94.10% | 96.40% | 93.50% |
 | MI | -0.0602 | 0.127 | 0.001 | 0.020 | 0.021 | 0.031 | 95.50% | 94.10% | 95.80% |
 | LMCF | -0.079 | 0.137 | -0.049 | 0.051 | 0.032 | 0.039 | 93.50% | 95.00% | 95.60% |
 | J2R (P-) | -0.100 | 0.149 | -0.006 | 0.016 | 0.050 | 0.054 | 92.70% | 95.40% | 94.30% |
 | CDR (P-) | -0.090 | 0.141 | -0.006 | 0.016 | 0.040 | 0.046 | 93.10% | 95.30% | 94.20% |
 | CR (P-) | -0.095 | 0.146 | -0.006 | 0.016 | 0.045 | 0.050 | 92.20% | 95.30% | 94.80% |
10% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | 0.112 | 0.157 | -0.017 | 0,022 | 0.028 | 0.035 | 89.50% | 94.50% | 95.00% |
 | MI | 0.112 | 0.158 | -0.018 | 0.024 | 0.030 | 0.040 | 90.50% | 95.50% | 95.00% |
 | LMCF | 0.095 | 0.150 | -0.103 | 0.104 | 0.040 | 0.046 | 92.50% | 87.50% | 95.50% |
 | J2R (P-) | 0.072 | 0.133 | -0.015 | 0.020 | 0.054 | 0.058 | 94.5% | 87.50% | 94.50% |
 | CDR (P-) | 0.088 | 0.143 | -0.015 | 0.020 | 0.046 | 0.051 | 92.50% | 86.50% | 96.00% |
 | CR (P-) | 0.078 | 0.136 | -0.015 | 0.020 | 0.052 | 0.057 | 93.50% | 88.50% | 95.50% |
20% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | -0.032 | 0.12 | -0.0024 | 0.017 | 0.024 | 0.034 | 95.00% | 94.50% | 95.00% |
 | MI | -0.042 | 0.124 | -0.005 | 0.022 | 0.033 | 0.045 | 94.50% | 95.50% | 95.00% |
 | LMCF | -0.099 | 0.154 | -0.183 | 0.183 | 0.078 | 0.083 | 93.50% | 90.50% % | 94.50% |
 | J2R (P-) | -0.122 | 0.164 | 0.0002 | 0.016 | 0.092 | 0.100 | 89.50% | 95.00% | 94.50% |
 | CDR (P-) | -0.074 | 0.134 | 0.0002 | 0.016 | 0.057 | 0.063 | 95.50% | 95.00% | 93.50% |
 | CR (P-) | -0.099 | 0.149 | 0.0002 | 0.016 | 0.073 | 0.075 | 94.50% | 95.00% | 94.50% |
30% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | -0.092 | 0.149 | -0.052 | 0.055 | 0.043 | 0.051 | 94.30% | 94.50% | 95.10% |
 | MI | -0.050 | 136 | -0.030 | 0.039 | 0.005 | 0.037 | 94.40% | 95.20% | 95.80% |
 | LMCF | -0.136 | 0.184 | -0.279 | 0.280 | 0.081 | 0.086 | 89.10% | 85.70% | 90.20% |
 | J2R (P-) | -0.220 | 0.252 | -0.059 | 0.062 | 0.138 | 0.141 | 85.20% | 94.50% | 87.40% |
 | CDR (P-) | -0.160 | 0.200 | -0.059 | 0.062 | 0.094 | 0.098 | 90.50% | 94.10% | 95.30% |
 | CR (P-) | -0.197 | 0.216 | -0.059 | 0.062 | 0.109 | 0.112 | 90.90% | 93.20% | 92.70% |
50% | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | ML | 0.036 | 0.123 | 0.0004 | 0.022 | 0.009 | 0.033 | 96.60% | 95.30% | 95.40% |
 | MI | 0.039 | 0.136 | -0.006 | 0.031 | 0.026 | 0.051 | 95.30% | 95.10% | 94.60% |
 | LMCF | -0.045 | 0.129 | -0.360 | 0.360 | 0.084 | 0.088 | 94.30% | 89.10% | 95.40% |
 | J2R (P-) | -0.112 | 0.159 | 0.0004 | 0.023 | 0.127 | 0.130 | 89.50% | 95.10% | 90.60% |
 | CDR (P-) | -0.045 | 0.121 | 0.0004 | 0.023 | 0.088 | 0.089 | 94.70% | 95.20% | 93.40% |
 | CR (P-) | -0.087 | 0.142 | 0.0004 | 0.023 | 0.112 | 0. 115 | 91.20% | 95.20% | 89.50% |